Molecular Formula | C25H31N7O |
Molar Mass | 445.56 |
Density | 1.21±0.1 g/cm3(Predicted) |
Boling Point | 676.5±65.0 °C(Predicted) |
Solubility | DMSO: ≥ 75 mg/mL |
pKa | 9.07±0.28(Predicted) |
Storage Condition | -20℃ |
Physical and Chemical Properties | Bioactive Mutated EGFR-IN-1 (Osimertinib analog) is an intermediate of mutant EGFR (L858R EGFR,Exonl9 deletion activation mutation and T790M resistance mutation) inhibitors. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.244 ml | 11.222 ml | 22.444 ml |
5 mM | 0.449 ml | 2.244 ml | 4.489 ml |
10 mM | 0.224 ml | 1.122 ml | 2.244 ml |
5 mM | 0.045 ml | 0.224 ml | 0.449 ml |